Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
16.7M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$417M
-
Value change
-
-$40.7M
-
Number of buys
-
67
-
Number of sells
-
-73
-
Price
-
$24.92
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q1 2020
165 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q1 2020.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.7M shares
of 22.7M outstanding shares and own 73.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.52M shares), Conestoga Capital Advisors, LLC (1.72M shares), VANGUARD GROUP INC (1.32M shares), DIMENSIONAL FUND ADVISORS LP (913K shares), GENEVA CAPITAL MANAGEMENT LLC (869K shares), Ranger Investment Management, L.P. (823K shares), STATE STREET CORP (671K shares), Copeland Capital Management, LLC (641K shares), PRINCIPAL FINANCIAL GROUP INC (528K shares), and Russell Investments Group, Ltd. (453K shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.